Titel

Merkliste
1 Ergebnisse

Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase ..:

Michael, M ; Groothoff, J. W ; Shasha-Lavsky, H...
info:eu-repo/semantics/altIdentifier/doi/10.1053/j.ajkd.2022.05.012. , 2022

Link: https://www.hal.inserm.fr/inserm-03831070

RT Journal
T1 <Title>Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:inserm-03831070v1&Exemplar=1&LAN=DE
				
A1 Michael, M
A1 Groothoff, J. W
A1 Shasha-Lavsky, H
A1 Lieske, J. C
A1 Frishberg, Y
A1 Simkova, E
A1 Sellier-Leclerc, A. L
A1 Devresse, A
A1 Guebre-Egziabher, F
A1 Bakkaloglu, S. A
A1 Mourani, C
A1 Saqan, R
A1 Singer, R
A1 Willey, R
A1 Habtemariam, B
A1 Gansner, J. M
A1 Bhan, I
A1 Mcgregor, T
A1 Magen, D
PB HAL CCSD; Elsevier
YR 2022
K1 Lumasiran
K1 RNA interference (RNAi)
K1 adverse events
K1 anti-drug antibodies
K1 cardiac dysfunction
K1 efficacy
K1 glycolate
K1 hemodialysis
K1 kidney disease
K1 nephrocalcinosis
K1 pediatric
K1 pharmacodynamics
K1 pharmacokinetics
K1 phase 3 clinical trial
K1 plasma oxalate (POx)
K1 primary hyperoxaluria type 1 (PH1)
K1 safety
K1 systemic oxalosis
K1 urinary oxalate (UOx)
K1 [SDV]Life Sciences [q-bio]
JF info:eu-repo/semantics/altIdentifier/doi/10.1053/j.ajkd.2022.05.012
LK http://dx.doi.org/https://www.hal.inserm.fr/inserm-03831070
DO https://www.hal.inserm.fr/inserm-03831070
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)